Multi-Drug Resistance Profile, Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Gram Negative Bacilli Among Admitted Patients After Surgery with Suspected of Surgical Site Nosocomial Infection North East Ethiopia

References

• Morris S, Cerceo E. Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics. 2020;9(4):196. doi:10.3390/antibiotics9040196
   Web of Science ®Google Scholar
• Rawat D, Nair D. Extended-spectrum β-lactamases in gram negative bacteria. J Glob Infect Dis. 2010;2(3):263. doi:10.4103/0974-777X.68531
   PubMedGoogle Scholar
• Cantón R. Co qu e TM. The CTX-M Be Ta-Lac Tama Se Pan de Mic. Curr Opin Mic Ro Bi Ol. 2006;9(5):466–475.
   PubMed Web of Science ®Google Scholar
• Wilmore SS, Kranzer K, Williams A, et al. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in Zimbabwe. J Med Microbiol. 2017;66(5):609–615. doi:10.1099/jmm.0.000474
   PubMed Web of Science ®Google Scholar
• Nature E. The antibiotic alarm. Nature. 2013;495(7440):141.
   Web of Science ®Google Scholar
• Brooks PT, Mansfield LS. Effects of antibiotic resistance (AR) and microbiota shifts on Campylobacter jejuni-mediated diseases. Anim Health Res Rev. 2017;18(2):99–111. doi:10.1017/S1466252318000014
   Web of Science ®Google Scholar
• Control CfD, Prevention. Antibiotic Resistance Threats in the United States, 2013. Atlanta, GA: CDC; 2013.
   Google Scholar
• Sangare SA, Rondinaud E, Maataoui N, et al. Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali. PLoS One. 2017;12(2):e0172652. doi:10.1371/journal.pone.0172652
   Web of Science ®Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791. doi:10.3201/eid1710.110655
   PubMed Web of Science ®Google Scholar
• Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci. 2018;6(1):1. doi:10.3390/medsci6010001
   Google Scholar
• Thomson KS. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol. 2010;48(4):1019–1025. doi:10.1128/JCM.00219-10
   PubMed Web of Science ®Google Scholar
• Babu R, Kumar A, Karim S, et al. Faecal carriage rate of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up. J Glob Antimicrob Resist. 2016;6:150–153. doi:10.1016/j.jgar.2016.05.007
   Web of Science ®Google Scholar
• Vialle‐Valentin C, Lecates R, Zhang F, Desta A, Ross‐Degnan D. Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countries. Trop Med Int Health. 2012;17(2):211–222. doi:10.1111/j.1365-3156.2011.02895.x
   Web of Science ®Google Scholar
• Khan M, Khalil J, Zarin M, et al. Rate and risk factors for surgical site infection at a tertiary care facility in Peshawar, Pakistan. J Ayub Med Coll Abbottabad. 2011;23(1):15–18.
   Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. Cambridge university press; 2005.
   Google Scholar
• Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology E-book. Elsevier Health Sciences; 2020.
   Google Scholar
• Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;58(3):e01864–e01919. doi:10.1128/JCM.01864-19
   PubMed Web of Science ®Google Scholar
• Magiorakos A-P, Srinivasan A, Carey R, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Lashoher A, Schneider EB, Juillard C, et al. Implementation of the World Health Organization Trauma Care Checklist Program in 11 centers across multiple economic strata: effect on care process measures. World J Surg. 2017;41(4):954–962. doi:10.1007/s00268-016-3759-8
   Web of Science ®Google Scholar
• Mama M, Abdissa A, Sewunet T. Antimicrobial susceptibility pattern of bacterial isolates from wound infection and their sensitivity to alternative topical agents at Jimma University Specialized Hospital, South-West Ethiopia. Ann Clin Microbiol Antimicrob. 2014;13(1):1–10. doi:10.1186/1476-0711-13-14
   Web of Science ®Google Scholar
• Dessie W, Mulugeta G, Fentaw S, Mihret A, Hassen M, Abebe E. Pattern of bacterial pathogens and their susceptibility isolated from surgical site infections at selected referral hospitals, Addis Ababa, Ethiopia. Int J Microbiol. 2016;2016:1–8. doi:10.1155/2016/2418902
   Google Scholar
• Mohammed A, Seid ME, Gebrecherkos T, Tiruneh M, Moges F. Bacterial isolates and their antimicrobial susceptibility patterns of wound infections among inpatients and outpatients attending the University of Gondar Referral Hospital, Northwest Ethiopia. Int J Microbiol. 2017;2017:1–10. doi:10.1155/2017/8953829
   Web of Science ®Google Scholar
• Roy S, Ahmed MU, Uddin BMM, et al. Evaluation of antibiotic susceptibility in wound infections: a pilot study from Bangladesh. F1000Research. 2017;6:2103. doi:10.12688/f1000research.12887.1
   Google Scholar
• Shimekaw M, Tigabu A, Tessema B. Bacterial profile, antimicrobial susceptibility pattern, and associated risk factors among patients with wound infections at Debre Markos Referral Hospital, Northwest, Ethiopia. Int J Low Extrem Wounds. 2020;21:1534734620933731.
   Web of Science ®Google Scholar
• Rijal BP, Satyal D, Parajuli NP. High burden of antimicrobial resistance among Bacteria causing pyogenic wound infections at a tertiary Care Hospital in Kathmandu, Nepal. J Pathog. 2017;2017:1–7. doi:10.1155/2017/9458218
   Web of Science ®Google Scholar
• Shabnum M. Microbial profile and antibiotic susceptibility pattern of orthopedic infections in a tertiary care hospital: a study from South India. Int J Med Sci Public Health. 2017;6(5):838–842.
   Google Scholar
• Omoregie AYEEC, Ohiorenuan R II, Onemu S, Onemu S. Microbiology of wound infections and its associated risk factors among patients of a Tertiary hospital in Benin City, Nigeria. J Res Health Sci. 2011;11:109–113.
   Google Scholar
• Zuarez-Easton S, Zafran N, Garmi G, Salim R. Postcesarean wound infection: prevalence, impact, prevention, and management challenges. Int J Womens Health. 2017;9:81. doi:10.2147/IJWH.S98876
   PubMed Web of Science ®Google Scholar
• Mitiku M, Ayenew Z, Desta K. Multi-drug resistant, extended spectrum beta-lactamase and carbapenemase producing bacterial isolates among septicemia suspected under five children in Tikur Anbessa specialized Hospital, Addis Ababa Ethiopia: cross-sectional study; 2019.
   Google Scholar
• Kano C. Carbapenem-Resistant Enterobacteriaceae (CRE) in Intensive Care Units and surgical wards of hospitals with no history of carbapenem usage in Kano, North West Nigeria. Niger J Microbiol. 2015;27(1):2612–2618.
   Google Scholar
• Alebel M, Mekonnen F, Mulu W. Extended-spectrum β-lactamase and carbapenemase producing gram-negative bacilli infections among patients in intensive care units of felegehiwot referral hospital: a prospective cross-sectional study. Infect Drug Resist. 2021;14:391. doi:10.2147/IDR.S292246
   Web of Science ®Google Scholar
• Beyene D, Bitew A, Fantew S, Mihret A, Evans M. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):e0222911. doi:10.1371/journal.pone.0222911
   PubMed Web of Science ®Google Scholar
• Kołpa M, Wałaszek M, Gniadek A, Wolak Z, Dobroś W. Incidence, microbiological profile and risk factors of healthcare-associated infections in intensive care units: a 10 year observation in a provincial hospital in Southern Poland. Int J Environ Res Public Health. 2018;15(1):112. doi:10.3390/ijerph15010112
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik A, Rizvi M, Ahmed M. Presence of metallo-beta-lactamases (MBL), extended-spectrum beta-lactamase (ESBL) & AmpC positive non-fermenting Gram-negative bacilli among Intensive Care Unit patients with special reference to molecular detection of blaCTX-M & blaAmpC genes. Indian J Med Res. 2016;144(2):271. doi:10.4103/0971-5916.195043
   Web of Science ®Google Scholar
• Uc-Cachón AH, Gracida-Osorno C, Luna-Chi IG, Jiménez-Guillermo JG, Molina-Salinas GM. High prevalence of antimicrobial resistance among gram-negative isolated bacilli in intensive care units at a tertiary-care hospital in Yucatán Mexico. Medicina. 2019;55(9):588. doi:10.3390/medicina55090588
   Web of Science ®Google Scholar
• Singh N, Pattnaik D, Neogi DK, Jena J, Mallick B. Prevalence of ESBL in Escherichia coli isolates among ICU patients in a tertiary care hospital. JCDR. 2016;10(9):DC19. doi:10.7860/JCDR/2016/21260.8544
   Google Scholar
• Kayastha K, Dhungel B, Karki S, et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting International Friendship Children’s Hospital, Kathmandu, Nepal. Infect Dis. 2020;13:1178633720909798. doi:10.1177/1178633720909798
   Google Scholar
• Kovacevic P, Zlojutro B, Kovacevic T, Baric G, Dragic S, Momcicevic D. Microorganisms profile and antibiotics sensitivity patterns in the only medical intensive care unit in Bosnia and Herzegovina. Microbial Drug Resist. 2019;25(8):1176–1181. doi:10.1089/mdr.2018.0458
   Web of Science ®Google Scholar
• Siddique SG, Bhalchandra MH, Wyawahare AS, Bansal VP, Mishra JK, Naik S. Prevalence of MRSA, ESBL and Carbapenemase producing isolates obtained from endotracheal and tracheal tubes secretions of ICU patient at tertiary care centre. Int J Curr Microbiol App Sci. 2017;6(4):288–299. doi:10.20546/ijcmas.2017.604.032
   Google Scholar
• Hamishehkar H, Shadmehr P, Mahmoodpoor A, Mashayekhi SO, Entezari-Maleki T. Antimicrobial susceptibility patterns among bacteria isolated from intensive care units of the largest teaching hospital at the northwest of Iran. Braz J Pharm Sci. 2016;52(3):403–412. doi:10.1590/s1984-82502016000300006
   Web of Science ®Google Scholar
• Lamichhane B, Thakur C, Jain S. Antibiotic resistance patterns of Gram-negative isolates in a tertiary care hospital of Nepal. Asian J Pharm Clin Res. 2014;7(3):30–33.
   Google Scholar
• Ghimire A, Acharya B, Tuladhar R. Extended Spectrum β-Lactamase (ESBL) producing multidrug resistant gram-negative bacteria from various clinical specimens of patients visiting a Tertiary Care Hospital. TUJM. 2017;4:1–8. doi:10.3126/tujm.v4i0.21667
   Google Scholar
• Moges F, Eshetie S, Abebe W, et al. High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PLoS One. 2019;14(4):e0215177. doi:10.1371/journal.pone.0215177
   PubMed Web of Science ®Google Scholar
• Abera B, Kibret M, Mulu W. Extended-Spectrum beta (β)-lactamases and Antibiogram in Enterobacteriaceae from clinical and drinking water Sources from Bahir Dar City, Ethiopia. PLoS One. 2016;11(11):e0166519. doi:10.1371/journal.pone.0166519
   PubMed Web of Science ®Google Scholar
• Lonchel CM, Melin P, Gangoué-Piéboji J, Assoumou M-C, Boreux R, De Mol P. Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals. Eur J Clin Microbiol Infect Dis. 2013;32(1):79–87. doi:10.1007/s10096-012-1717-4
   Web of Science ®Google Scholar
• Vinodhini R, Moorthy K, Palanivel P, et al. Detection and antimicrobial susceptibility pattern of ESBL producing Gram negative bacteria. Asian J Pharm Clin Res. 2014;7(1):243–247.
   Google Scholar
• Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and Ampc β lactamases producing superbugs–havoc in the intensive care units of Punjab India. JCDR. 2013;7(1):70. doi:10.7860/JCDR/2012/5016.2673
   Google Scholar
• Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) a. Clin Infect Dis. 2013;57(4):e22–e121. doi:10.1093/cid/cit278
   PubMed Web of Science ®Google Scholar
• Ahmed MAS, Bansal D, Acharya A, et al. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control. 2016;5(1):1–6. doi:10.1186/s13756-015-0100-5
   Web of Science ®Google Scholar
• Saeed NK, Kambal AM, El-Khizzi NA. Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Med J. 2010;31(12):1341–1349.
   Web of Science ®Google Scholar
• Nedjai S, Barguigua A, Djahmi N, et al. Prevalence and characterization of extended spectrum beta-lactamase-producing Enterobacter cloacae strains in Algeria. J Infect Dev Ctries. 2013;7(11):804–811. doi:10.3855/jidc.3127
   Web of Science ®Google Scholar
• Marie MA, John J, Krishnappa LG, Gopalkrishnan S. Molecular characterization of the β‐lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia. Microbiol Immunol. 2013;57(12):805–810. doi:10.1111/1348-0421.12104
   Web of Science ®Google Scholar
• Habeeb MA, Sarwar Y, Ali A, Salman M, Haque A. Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan. Pak J Med Sci. 2013;29(2):540. doi:10.12669/pjms.292.3144
   PubMed Web of Science ®Google Scholar
• Olowo-Okere A, Ibrahim YKE, Olayinka BO. Molecular characterisation of extended-spectrum β-lactamase-producing Gram-negative bacterial isolates from surgical wounds of patients at a hospital in North Central Nigeria. J Glob Antimicrob Resist. 2018;14:85–89. doi:10.1016/j.jgar.2018.02.002
   Web of Science ®Google Scholar
• Katip W, Yoodee J, Uitrakul S, Oberdorfer P. Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae. Sci Rep. 2021;11(1):1–8. doi:10.1038/s41598-020-78098-4
   PubMed Web of Science ®Google Scholar
• Andrew B, Kagirita A, Bazira J. Prevalence of extended-spectrum beta-lactamases-producing microorganisms in patients admitted at KRRH, Southwestern Uganda. Int J Microbiol. 2017;2017:1–5. doi:10.1155/2017/3183076
   Web of Science ®Google Scholar
• Ibrahim ME, Bilal NE, Magzoub MA, Hamid ME. Prevalence of extended-spectrum β-lactamases-producing Escherichia coli from Hospitals in Khartoum State, Sudan. Oman Med J. 2013;28(2):116. doi:10.5001/omj.2013.30
   Google Scholar
• Saharman YR, Lestari DC. Phenotype characterization of Beta-lactamase producing Enterobacteriaceae in the intensive care unit (ICU) of Cipto Mangunkusumo hospital in 2011. Acta Medica Indonesiana. 2016;45:1.
   Google Scholar
• Hecini-Hannachi A, Bentchouala C, Lezzar A, Laouar H, Benlabed K, Smati F. Multidrug-resistant bacteria isolated from patients hospitalized in Intensive Care Unit in University Hospital of Constantine, Algeria (2011–2015). Afr J Microbiol Res. 2016;10(33):1328–1336. doi:10.5897/AJMR2016.8257
   Google Scholar
• Qaddumi JA, Nazzal Z, Yacoup AR, Mansour M. Quality of death notification forms in North West Bank/Palestine: a descriptive study. BMC Res Notes. 2017;10(1):1–6. doi:10.1186/s13104-017-2469-0
   Google Scholar
• Leite CAK, Oizumi KY, Caleffi-Ferracioli KR, et al. β-lactamase-producing Gram-negative bacteria in an intensive care unit in southern Brazil. Braz J Pharm Sci. 2017;22:53.
   Google Scholar
• Ibrahim ME, Abbas M, Al-Shahrai AM, Elamin BK. Phenotypic characterization and antibiotic resistance patterns of extended-spectrum β -lactamase- and AmpC β -lactamase-producing gram-negative bacteria in a referral hospital, Saudi Arabia. Can J Infect Dis Med Microbiol. 2019;2019:1–9. doi:10.1155/2019/6054694
   Web of Science ®Google Scholar
• Manoharan A, Sugumar M, Kumar A, Jose H, Mathai D. Group I-Es. Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers. Indian J Med Res. 2012;135(3):359.
   Web of Science ®Google Scholar
• Abdalhamid B, Albunayan S, Shaikh A, Elhadi N, Aljindan R. Prevalence study of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals. J Med Microbiol. 2017;66(9):1286–1290. doi:10.1099/jmm.0.000504
   Web of Science ®Google Scholar
• Chang -Y-Y, Chuang Y-C, Siu LK, et al. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2015;48(2):219–225. doi:10.1016/j.jmii.2014.05.010
   PubMedGoogle Scholar
• Stocchetti N, Carbonara M, Citerio G, et al. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017;16(6):452–464. doi:10.1016/S1474-4422(17)30118-7
   PubMed Web of Science ®Google Scholar
• Makharita RR, El-Kholy I, Hetta HF, et al. Antibiogram and genetic characterization of carbapenem-resistant gram-negative pathogens incriminated in healthcare-associated infections. Infect Drug Resist. 2020;13:3991. doi:10.2147/IDR.S276975
   PubMed Web of Science ®Google Scholar
• Ramana K, Rao R, Sharada CV, Kareem M, Reddy LR, Mani MR. Modified Hodge test: a useful and the low-cost phenotypic method for detection of carbapenemase producers in Enterobacteriaceae members. J Nat Sci Biol Med. 2013;4(2):346. doi:10.4103/0976-9668.117009
   Google Scholar
• Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(suppl_3):S97–S100. doi:10.1093/cid/ciu542
   PubMed Web of Science ®Google Scholar
• Mushi MF, Mshana SE, Imirzalioglu C, Bwanga F. Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania. Biomed Res Int. 2014;2014:1–6. doi:10.1155/2014/303104
   Web of Science ®Google Scholar
• Katip W, Uitrakul S, Oberdorfer P. Clinical efficacy and nephrotoxicity of the loading dose colistin for the treatment of carbapenem-resistant Acinetobacter baumannii in critically ill patients. Pharmaceutics. 2021;14(1):31. doi:10.3390/pharmaceutics14010031
   PubMed Web of Science ®Google Scholar
• Katip W, Oberdorfer P. Clinical efficacy and nephrotoxicity of colistin alone versus colistin plus vancomycin in critically ill patients infected with carbapenem-resistant Acinetobacter baumannii: a propensity score-matched analysis. Pharmaceutics. 2021;13(2):162. doi:10.3390/pharmaceutics13020162
   PubMed Web of Science ®Google Scholar
• Katip W, Oberdorfer P, Kasatpibal N. Effectiveness and nephrotoxicity of loading dose colistin–meropenem versus loading dose colistin–imipenem in the treatment of carbapenem-resistant Acinetobacter baumannii infection. Pharmaceutics. 2022;14(6):1266. doi:10.3390/pharmaceutics14061266
   PubMed Web of Science ®Google Scholar
• Wanla W, Katip W, Supakul S, Apiwatnakorn P, Khamsarn S. Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation. Int J Gen Med. 2017;10:443. doi:10.2147/IJGM.S145133
   PubMed Web of Science ®Google Scholar